MAX and neoplasm: We acknowledge several limitations to the present study: a) the absence of carriers of mutations in the TMEM127/SDHAF2/MAX/SDHA genes; and b) the absence of screening of tumors for somatic mutations, mainly in apparently sporadic tumors, that could potentially occur and influence the presented tumor metabolomic profiles.